Bone Therapeutics celebrates ten years of innovation in bone cell therapy
Gosselies, Belgium, 3 June 2016 - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in the fields of bone fracture repair, fracture prevention and spinal fusion, today celebrates its ten-year anniversary with an evening event which will bring together guests from industry, government and the media as well as representatives of the international scientific community. The event will be attended by Mr Paul Magnette, Minister-President of Wallonia and Mr Jean-Claude Marcourt, Vice-President and Minister of Economy, Industry, Innovation and New Technologies of the Walloon Government.
Enrico Bastianelli, CEO of Bone Therapeutics commented: "We are proud of what we have achieved in the ten years since Bone Therapeutics was founded in 2006. We have come a long way, with two products in the clinic, six clinical trials and preparations underway to initiate trials in the US. We are grateful for the support of our investors, as well as the Walloon Government, without whom this would not have been possible. We want to mark this ten-year milestone in the company’s history, and look forward to the next ten years of progress."
Paul Magnette, Minister-President of Wallonia and Mayor of Charleroi said: "Bone Therapeutics is a great example of how dynamic, high technology companies enhance the economy and social fabric of Wallonia, creating employment and bringing innovation to the region. Wallonia has established a leadership position in the field of cell therapy in part through the achievements of companies like Bone Therapeutics and their contributions to this endeavour."
Jean-Claude Marcourt, Vice-President and Minister of Economy, Industry, Innovation and New Technologies of the Walloon Government, adds: "Over the past decade, Wallonia has seen its biotechnology industry grow significantly and it is now at the forefront in the field of cell therapy. An important contributory factor was the creation of Biowin, the health cluster of Wallonia. This initiative, which has a broad international reach, creates the perfect ecosystem for emerging biotech companies to thrive. The Walloon region has supported and keeps on supporting innovative ventures, like Bone Therapeutics, that strengthen its position."
Since its foundation in 2006 as a spin-off from the Université Libre de Bruxelles (ULB: Brussels, Belgium), Bone Therapeutics has focused on developing a technology initiated at the Erasme Hospital of the ULB. The Company has built on these initial foundations and is now running clinical trials in six indications. With the support of its shareholders and the Walloon Region, the Company has grown significantly over the past ten years, employing over 100 people, and has established its position as a leader in the field of bone cell therapy.